PharmAlliance-Flurbiprofen BP-100mg-Tablets

PharmAlliance-Flurbiprofen BP-100mg-Tablets

Add to Quote

Product Details

Introducing PharmAlliance International Labs Private Limited’s Flurbiprofen Range: Redefining Pain Relief and Inflammation Management

Welcome to PharmAlliance International Labs Private Limited, where innovation meets excellence in pharmaceutical solutions. Our Flurbiprofen Range stands as a beacon of hope for those seeking effective pain relief and inflammation management. As a global leader in healthcare, we are committed to delivering high-quality pharmaceutical products that enhance patient well-being and quality of life.

Understanding Drug Classification:

Within the esteemed class of nonsteroidal anti-inflammatory drugs (NSAIDs), Flurbiprofen reigns supreme. By inhibiting the synthesis of prostaglandins, this potent medication tackles pain, inflammation, and fever with precision and efficacy.

Exploring Formulations for Optimal Relief:

Experience the versatility of Flurbiprofen through our meticulously crafted tablets, available in 50mg and 100mg formulations. Designed for oral administration, each pack contains 30 tablets, ensuring convenience and ease of use for patients worldwide.

Indications: Empowering Patients on Their Healing Journey:

From the throes of rheumatoid arthritis to the relentless onslaught of dental pain, Flurbiprofen emerges as a steadfast ally in the fight against various inflammatory and painful conditions. Whether it’s osteoarthritis, ankylosing spondylitis, acute gout, or primary dysmenorrhea, our Flurbiprofen Range offers respite and relief.

Guiding Usage for Optimal Outcomes:

Navigating the path to pain relief requires precision and care. Our Flurbiprofen tablets are intended for oral administration, with dosage and treatment duration tailored to individual patient needs. To mitigate gastrointestinal side effects, it is advisable to take Flurbiprofen with food or milk.

Optimizing Dosage for Personalized Care:

Precision dosing lies at the heart of effective pain management. The recommended dosage of Flurbiprofen ranges from 100mg to 300mg per day, strategically divided into two to four doses. For mild to moderate pain or inflammation, a starting dose of 50mg to 100mg every 4 to 6 hours may suffice.

Navigating Pharmacokinetic Realms:

Embark on a journey through Flurbiprofen’s pharmacokinetic landscape, where absorption is rapid, distribution is widespread, and metabolism is intricate. With an elimination half-life of 3 to 6 hours, Flurbiprofen ensures sustained relief while minimizing the risk of adverse events.

Harmonizing Pharmacodynamics for Optimal Relief:

Embrace the therapeutic symphony of Flurbiprofen as it orchestrates relief by staunchly inhibiting cyclooxygenase enzymes and curtailing the synthesis of inflammatory prostaglandins. Through its anti-inflammatory, analgesic, and antipyretic effects, Flurbiprofen heralds a new dawn in pain management.

Prioritizing Safety Amidst the Pursuit of Relief:

While Flurbiprofen offers a glimmer of hope in the realm of pain relief, safety remains our utmost priority. Vigilance is key in mitigating common side effects such as gastrointestinal disturbances and renal impairment. Through proactive risk management and adherence to prescribed regimens, we endeavor to safeguard patient well-being.

Conclusion:

In conclusion, PharmAlliance International Labs Private Limited’s Flurbiprofen Range epitomizes a fusion of science, compassion, and innovation in the pursuit of pain relief excellence. As pioneers in pharmaceutical solutions, we invite you to embark on a transformative journey towards a future free from the shackles of pain. For more information on our Flurbiprofen Range and other cutting-edge pharmaceutical products, please don’t hesitate to contact us. Together, let’s pave the way for a healthier, pain-free tomorrow.

Reviews

There are no reviews yet.

Be the first to review “PharmAlliance-Flurbiprofen BP-100mg-Tablets”

Your email address will not be published. Required fields are marked *

Pharmalliance.pk© 2024. All rights reserved. Terms of Use and Privacy Policy